Chemanol buys Addar stake
Saudi firm Chemanol has signed a share purchase agreement to acquire an 84% stake in Addar Chemicals for $12.3 million in cash. This is contingent on meeting predefined performance indicators and achieving a targeted return on investment. The transaction is due to be completed on 31 March 2024.
The aim of the acquisition is to boost Chemanol’s market share in speciality chemicals and diversifying its product range. The company said that it would also reduce Addar’s production costs by integrating its services with its own. Chemanol will also provide raw materials to Addar and make some of Addar’s products in its own facilities.
RELATED ARTICLES
Travertine Technologies and precious metal refiner Sabin Metal have announced plans have revealed plans to build a demonstration plant at Sabin’s main facility near Rochester, New York.
Two CDMOs have separately announced expansions in their antibody-drug conjugate (ADC) manufacturing capabilities and capacity on opposite sides of the Atlantic.
OCSiAl has opened its first European graphene nanotubes facility in Serbia. It will produce 60 tonnes/year under the Tuball band and the company plans to double this by launching a second synthesis unit within the next year. The modular design means it is able to scale production rapidly.
A pilot enforcement project carried out by national enforcement authorities in 13 European Economic Area (EEA) countries between November 2023 and April 2024 found that 6% of about 4,500 cosmetic products inspected contained hazardous substances.
Biosynth, which supplies critical raw materials and services for diagnostics, vaccines and pharmaceuticals, has officially opened its Biosynth Biological Technology site at Lifebay, a technology park in Suzhou, China.
Spanish energy and chemicals company Cepsa has renamed itself Moeve.
